Salus Thomas D. has filed 8 insider transactions across 1 company since April 2025.
Most recent transaction: a grant/award of 30000 shares of LIFECORE BIOMEDICAL, INC. DE ($LFCR) on March 02, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 2, 2026 | LIFECORE BIOMEDICAL, INC. DE | $LFCR | Salus Thomas D. | Chief Legal & Administration | A | Common Stock | 30000 | $0.00 | 270,978.0000 | 37,466,352 | 12.45% | 0.08% |
| July 8, 2025 | LIFECORE BIOMEDICAL, INC. DE | $LFCR | Salus Thomas D. | Chief Legal & Administration | F | Common Stock | 11022 | $8.19 | 240,978.0000 | 0 | 4.37% | 0.00% |
| July 8, 2025 | LIFECORE BIOMEDICAL, INC. DE | $LFCR | Salus Thomas D. | Chief Legal & Administration | M | Performance-Based Restricted Stock Units | 37000 | $0.00 | 333,000.0000 | 0 | 10.00% | 0.00% |
| July 8, 2025 | LIFECORE BIOMEDICAL, INC. DE | $LFCR | Salus Thomas D. | Chief Legal & Administration | M | Common Stock | 37000 | $0.00 | 252,000.0000 | 0 | 17.21% | 0.00% |
| April 14, 2025 | LIFECORE BIOMEDICAL, INC. DE | $LFCR | Salus Thomas D. | Chief Legal & Administration | A | Common Stock | 170000 | $0.00 | 215,000.0000 | 0 | 377.78% | 0.00% |
| April 14, 2025 | LIFECORE BIOMEDICAL, INC. DE | $LFCR | Salus Thomas D. | Chief Legal & Administration | A | Performance-Based Restricted Stock Units | 370000 | $0.00 | 0.0000 | 0 | 0.00% | 0.00% |
| April 14, 2025 | LIFECORE BIOMEDICAL, INC. DE | $LFCR | Salus Thomas D. | Chief Legal & Administration | A | Incentive Stock Option (Right to Buy) | 210000 | $0.00 | 210,000.0000 | 0 | 9999.99% | 0.00% |
| April 14, 2025 | LIFECORE BIOMEDICAL, INC. DE | $LFCR | Salus Thomas D. | Chief Legal & Administration | A | Common Stock | 45000 | $0.00 | 45,000.0000 | 0 | 9999.99% | 0.00% |